Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Candice L Clarke

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of the American Society of Nephrology : JASN|October 1, 2020
Authors' ReplyCandice L Clarke, Maria Prendecki, Stephen P McAdoo, et al.
Kidney International Reports|April 18, 2022
Comparison of Vaccine Effectiveness Against the Omicron (B.1.1.529) Variant in Hemodialysis PatientsKatrina J Spensley, Sarah Gleeson, Paul Martin, et al.
Oxford Open Immunology|August 30, 2021
Protease inhibitor plasma concentrations associate with COVID-19 infectionNicholas R Medjeral-Thomas, Anne Troldborg, Annette G Hansen, et al.
The Lancet Regional Health. Europe|September 15, 2022
Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort studyPaul Martin, Sarah Gleeson, Candice L Clarke, et al.
Frontiers in Immunology|May 17, 2021
Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal DiseaseNicholas R Medjeral-Thomas, Anne Troldborg, Annette G Hansen, et al.
Lancet (London, England)|October 7, 2021
Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipientsMaria Prendecki, Tina Thomson, Candice L Clarke, et al.
Eclinicalmedicine|September 15, 2022
Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipientsTina Thomson, Maria Prendecki, Sarah Gleeson, et al.
Nature Communications|December 15, 2022
Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescenceJack S Gisby, Norzawani B Buang, Artemis Papadaki, et al.
Kidney International|March 28, 2021
Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfectionCandice L Clarke, Maria Prendecki, Amrita Dhutia, et al.
Elife|March 11, 2021
Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of deathJack Gisby, Candice L Clarke, Nicholas Medjeral-Thomas, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of the American Society of Nephrology : JASN|October 1, 2020
Authors' ReplyCandice L Clarke, Maria Prendecki, Stephen P McAdoo, et al.
Kidney International Reports|April 18, 2022
Comparison of Vaccine Effectiveness Against the Omicron (B.1.1.529) Variant in Hemodialysis PatientsKatrina J Spensley, Sarah Gleeson, Paul Martin, et al.
Oxford Open Immunology|August 30, 2021
Protease inhibitor plasma concentrations associate with COVID-19 infectionNicholas R Medjeral-Thomas, Anne Troldborg, Annette G Hansen, et al.
The Lancet Regional Health. Europe|September 15, 2022
Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort studyPaul Martin, Sarah Gleeson, Candice L Clarke, et al.
Frontiers in Immunology|May 17, 2021
Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal DiseaseNicholas R Medjeral-Thomas, Anne Troldborg, Annette G Hansen, et al.
Lancet (London, England)|October 7, 2021
Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipientsMaria Prendecki, Tina Thomson, Candice L Clarke, et al.
Eclinicalmedicine|September 15, 2022
Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipientsTina Thomson, Maria Prendecki, Sarah Gleeson, et al.
Nature Communications|December 15, 2022
Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescenceJack S Gisby, Norzawani B Buang, Artemis Papadaki, et al.
Kidney International|March 28, 2021
Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfectionCandice L Clarke, Maria Prendecki, Amrita Dhutia, et al.
Elife|March 11, 2021
Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of deathJack Gisby, Candice L Clarke, Nicholas Medjeral-Thomas, et al.
Pageof 2